There has been a lot of buying in nano cap Stellar Biotechnologies (OTCQB:SBOTF +8.7%) since late July. Prices almost quadrupled from the July 21, 2014 low of $0.60 to the peak of $2.36 on August 28 on a huge increase in volume. Profit taking took over for the next few days, but prices bullishly rebounded as they approached the 50-day EMA albeit on lower volume.
Stellar's business is based on the immune-stimulating protein Keyhole Limpet Hemocyanin (KLH). It maintains an aquaculture facility to cultivate Giant Keyhole Limpets to ensure a constant supply of the protein. KLH is an active ingredient in some pharmaceutical products and certain immunotherapeutic product candidates.
Sales for fiscal Q3 were only ~$100K, however. Its cash balance at quarter's end was $14.8M which management stated was sufficient to fund the company's operations through 2015.